Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
WuXi Biologics Receives Bioprocessing Excellence Award from IMAPAC
2022-04-15 09:03
WuXi Biologics Achieved Record Growth and Profitability in 2021
2022-03-23 00:38
WuXi Biologics Recognized as 2022 Top-Rated ESG Company by Sustainalytics
2022-03-14 20:30
WuXi Biologics Wins CMO Leadership Awards in All Six Core Categories for Fifth Consecutive Year
2022-03-02 10:07
WuXi Biologics Statement
2022-02-08 11:08
WuXi Biologics Completes GMP Inspection by South Korea's Ministry of Food and Drug Safety for Drug Substance Facility
2022-01-18 10:50
WuXi Biologics Launches a New GMP Commercial Drug Product Facility
2021-11-01 10:19
WuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility
2021-10-28 08:30
WuXi Biologics Received First Manufacturing License from Japan and Completed 12 Global Regulatory Inspections in 2021 Year to Date
2021-09-01 14:12
WuXi Biologics Reports Strong 2021 Interim Results
2021-08-23 20:59
WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate
2021-08-02 20:13
WuXi Biologics Received Commercial Manufacturing License from German Health Authorities for its German Drug Product Facility
2021-07-26 18:00
WuXi XDC and LegoChem Biosciences Signed Memorandum of Understanding for the Development and Manufacturing of Antibody-drug Conjugates
2021-06-10 08:30
WuXi Biologics and OncoC4 Establish Exclusive CDMO Partnership
2021-05-27 08:30
WuXi Biologics and WuXi STA Jointly Established WuXi XDC to Provide Fully Integrated Bioconjugate CDMO Services
2021-05-14 08:30
WuXi Biologics Completed Three Acquisitions to Enhance its Global Network
2021-05-07 08:30
WuXi Biologics Receives 2021 Asia-Pacific Bioprocessing Excellence Award from IMAPAC
2021-04-13 17:00
WuXi Biologics Successfully Completed Pre-License Inspection and Routine GMP Inspection by U.S. FDA
2021-04-07 08:22
2020 Results Record High Despite a Challenging Year
2021-03-23 20:59
WuXi Biologics to Acquire CMAB and Form Strategic Partnership with CBC Group
2021-03-18 08:59
1
2
3
4
5
9